TW202419091A - 布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物 - Google Patents
布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物 Download PDFInfo
- Publication number
- TW202419091A TW202419091A TW112127725A TW112127725A TW202419091A TW 202419091 A TW202419091 A TW 202419091A TW 112127725 A TW112127725 A TW 112127725A TW 112127725 A TW112127725 A TW 112127725A TW 202419091 A TW202419091 A TW 202419091A
- Authority
- TW
- Taiwan
- Prior art keywords
- bruton
- tyrosine kinase
- pharmaceutical formulations
- kinase inhibitor
- conditions
- Prior art date
Links
- 229940125814 BTK kinase inhibitor Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 229940124291 BTK inhibitor Drugs 0.000 abstract 1
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- XYFPWWZEPKGCCK-GOSISDBHSA-N ibrutinib Chemical compound C1=2C(N)=NC=NC=2N([C@H]2CN(CCC2)C(=O)C=C)N=C1C(C=C1)=CC=C1OC1=CC=CC=C1 XYFPWWZEPKGCCK-GOSISDBHSA-N 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Abstract
本文描述布魯東氏酪胺酸激酶(Btk)抑制劑1-((R)-3-(4-胺基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-1-基)哌啶-1-基)丙-2-烯-1-酮之醫藥調配物。亦揭示單獨或與其他治療劑組合使用該Btk抑制劑治療自體免疫疾病或病狀、異種免疫疾病或病狀、包括淋巴瘤之癌症及發炎性疾病或病狀的方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/127,717 | 2015-03-03 | ||
US62/193,518 | 2015-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202419091A true TW202419091A (zh) | 2024-05-16 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021015368A (es) | Composiciones farmaceuticas de un inhibidor de tirosina cinasa de bruton. | |
JOP20200222A1 (ar) | أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون | |
MX2017001671A (es) | Formulaciones novedosas de un inhibidor de la tirosina cinasa de bruton. | |
PH12020552065A1 (en) | Ibrutinib combination therapy | |
MX2017012411A (es) | Co-cristales de un inhibidor de tirosina cinasa de bruton. | |
MX2017012430A (es) | Formas solvatadas de un inhibidor de tirosina quinasa de bruton. | |
WO2016196776A3 (en) | Inhibitors of bruton's tyrosine kinase | |
PH12015502053A1 (en) | Combinations of bruton's tyrosine kinase inhibitors and cyp3a4 inhibitors | |
MX2019008815A (es) | Sintesis de un inhibidor de tirosina quinasa de bruton. | |
EA201690746A1 (ru) | Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии | |
WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
WO2018033941A3 (en) | Pharmaceutical compositions of ibrutinib | |
MX2019000159A (es) | Pirrolo[2,3-d]piridazin-4-onas sustituidas y pirazolo[3,4-d]pirida zin-4-onas como inhibidores de la proteina quinasa. | |
TW202419091A (zh) | 布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物 | |
AR103832A1 (es) | Formulaciones farmacéuticas de un inhibidor de tirosina quinasa de bruton | |
AR098210A1 (es) | Combinaciones de inhibidores de la tirosina quinasa de bruton e inmunoterapias | |
TH1401007895A (th) | สารยับยั้ง PI3K เดลต้าแบบเลือกจำเพาะ (Selective Pi3k Delta Inhibitors) |